RANDOMIZED, OPEN LABEL, ACTIVE CONTROLLED STUDY TO ASSESS AND COMPARE HEALTH RELATED QUALITY OF LIFE WITH MOMETASONE & FORMOTEROL VERSUS FLUTICASONE & FORMOTEROL DRY POWDER INHALER IN MILD TO MODERATE PERSISTENT ASTHMA

Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2015, Vol 8, Issue 4

Abstract

ABSTRACTObjectives: The present study was under taken to assess and compare the improvement in HRQoL among mild to moderate persistent asthmabetween Mometasone & Formoterol versus Fluticasone & Formoterol using dry powder inhaler using Asthma HRQoL questionnaire which is diseasespecific32-item instrument including 4 domains: symptoms, emotions, exposure to environmental stimuli and activity limitations where impairmentsexperienced during the previous 14 days and respond on 7-point scale.Methods: The present study was conducted in Preventive Medicine Unit and Chest & TB diseases OPD, KIMS & RC, Bangalore during March 2011 toFebruary 2012. 60 patients were recruited in each group based on inclusion and exclusion criteria. PFT was done pre and post bronchodilator withSalbutamol nebulization with Spirometry. Study medications were randomized and were given for 12weeks. HRQoL questionnaire was administeredbefore and after the medications and outcome was compared between them. Statistical test used were descriptive statistics, t- test.Results: There was a significant improvement in HRQoL from baseline to the end of 12 weeks in all domains (symptoms, emotional, exposure toenvironmental stimuli and activity limitations) in both the groups. The overall improvement in the HRQoL was better in Mometasone & Formoterolgroup compared to Fluticasone & Formoterol group but this difference was not statistically significant, which revealed both combinations wereequally effective in improving HRQoL in mild to moderate persistent asthma.Conclusion: Both Mometasone & Formoterol and Fluticasone & Formoterol combinations are equally effective in improving HRQoL in mild tomoderate persistent asthma patients.Keywords: Health-related quality of life, Mild to moderate persistent asthma, Dry powder inhaler.

Authors and Affiliations

Sathish Chandra, Huliraj N, Giriyanna Gowda, Gangaboraiah . , Parasuramalu Bg

Keywords

Related Articles

ASSESSMENT OF ANTIOXIDATIVE AND AMELIORATIVE POTENTIAL OF AQUEOUS EXTRACT OF LEAVES OF THUJA ORIENTALIS (PLATYCLADUS ORIENTALIS [L.])

Objective: The main objective of the present study is to assess the antioxidative and attenuating potential of aqueous extract of leaves of Thuja orientalis (AET) against the genotoxicity induced by chlorpyrifos (CPF) (O...

COMPARISON OF CARTILAGE TYPE IIIA AND IIIB TYMPANOPLASTY IN INDIAN PATIENTS WITH CHRONIC SUPPURATIVE OTITIS MEDIA

Objective: This prospective comparative study determined the efficacy of type III tympanoplasty using homologous septal spur cartilage in patients with chronic otitis medis (COM).Methods: We selected patients by random s...

ANTIFUNGAL AND ANTIBACTERIAL ACTIVITIES OF JUICE AND ETHANOLIC EXTRACTS OF GARCINIA MANGOSTANA L. LEAVES

Objective: Garcinia mangostana is a plant that can be used as a traditional medicine to treat various infectious diseases for the treatment of diarrhea, skin infection, and chronic wounds. The activity as antifungal and...

STUDY OF ANTIOBESITY ACTIVITY OF POLYHERBAL FORMULATION IN CORRELATION WITH ANTIDIABETIC ACTIVITY

Objective: The objective of this research was to develop a polyherbal formulation using four different herbs using obese diabetic rat’s model. Methods: Rats received high-fat diet and alloxan was injected intraperitone...

PHYTOCHEMICAL MANAGEMENT OF DIABETIC COMPLICATIONS, EXPERIMENTAL EVIDENCES

It is progressively obvious that not only is a cure for the current worldwide diabetes epidemic required but also for its major complications, affecting both small and large blood vessels. These complications occur in th...

Download PDF file
  • EP ID EP605807
  • DOI -
  • Views 105
  • Downloads 0

How To Cite

Sathish Chandra, Huliraj N, Giriyanna Gowda, Gangaboraiah . , Parasuramalu Bg (2015). RANDOMIZED, OPEN LABEL, ACTIVE CONTROLLED STUDY TO ASSESS AND COMPARE HEALTH RELATED QUALITY OF LIFE WITH MOMETASONE & FORMOTEROL VERSUS FLUTICASONE & FORMOTEROL DRY POWDER INHALER IN MILD TO MODERATE PERSISTENT ASTHMA. Asian Journal of Pharamceutical and Clinical Research, 8(4), 296-298. https://europub.co.uk/articles/-A-605807